Table 2.
Demographic and clinical details of patients with Parkinson's disease, atypical parkinsonian syndromes and healthy controls.
| PD (n = 45) | APS (n = 20) | HC (n = 35) | PD vs HC | APS vs HC | PD vs APS | |
|---|---|---|---|---|---|---|
| Gender (M: F) | 32:13 | 13:07 | 22:13 | 0.47 | 1.00 | 0.77 |
| Age | 58.00 ± 8.70 | 53.65 ± 7.19 | 55.00 ± 5.40 | 0.07 | 0.43 | 0.06 |
| Age at onset | 51.90 ± 8.64 | 50.95 ± 7.59 | – | – | – | 0.67 |
| Duration of illness⁎ | 6.26 ± 4.06 | 2.80 ± 1.38 | – | – | – | 0.0005 |
| UPDRS III (OFF) | 36.58 ± 13.66 | NA | – | – | – | – |
| H & Y stage | 1.70 ± 0.54 | – | – | – | – | – |
APS: Atypical parkinsonian syndromes; F: Female; H & Y: Hoehn and Yahr; HC: Healthy controls; M: Male; NA: Not applicable; UPDRS: Unified Parkinson's disease rating scale.
⁎
PD vs Atypical parkinsonian syndromes p < .01.